Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    This reflects a minor ClinicalTrials.gov site/UI release update (revision label changed to v3.5.3) without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-04-26T15:43:58.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:13:18.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Carcinosarcoma of the corpus uteri as an associated condition reference and included a link to the Genetic and Rare Diseases Information Center in the Resources section.
    Difference
    0.1%
    Check dated 2026-03-29T03:52:59.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:10:52.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new site revision v3.4.3 was added and the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.4.2) replacing the previous (v3.4.1). This appears to be a cosmetic version update.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:37.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.